Recursion Pharmaceuticals Inc vs SoFi Technologies Inc — how do they compare? Recursion Pharmaceuticals Inc trades at $3.08 (market cap $1.53B), while SoFi Technologies Inc trades at $17.62 (market cap $21.82B). The key difference: SoFi Technologies Inc is far larger — about 14.3× Recursion Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| RXRX | SOFI | |
|---|---|---|
Market Cap | $1.53B | $21.82B |
Sector | Health | Financials |
52-Week High | $6.79 | $32.21 |
52-Week Low | $2.84 | $15.15 |
Enterprise Value | $946.50M | — |
Trailing returns across standard periods
Latest headlines on both assets
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →SoFi is a financial services company that was founded in 2011 and is currently based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020 the company also offers payment and account services for debit cards and digital banking.
Read more on SOFI →